Cell-cell adhesion molecules and their associated proteins in bladder cancer cells and their role in mitogen induced cell-cell dissociation and invasion

Anticancer Research

Volumn 19, Issue 1 A, 1999, Pages 547-552

  Davies, G ^a   Jiang, W G ^a   Mason, M D ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

catenin; Bladder cancer; Desmoglein; E cadherin; Hepatocyte growth factor

Indexed keywords

ALPHA CATENIN; ANTIBODY; BETA CATENIN; CATENIN; CELL ADHESION MOLECULE; DESMOGLEIN; DESMOPLAKIN; SCATTER FACTOR; UVOMORULIN;

ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CELL ADHESION; CELL INVASION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

ANIMALS; BETA CATENIN; CADHERINS; CYTOSKELETAL PROTEINS; DESMOGLEINS; DESMOPLAKINS; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; NEOPLASM INVASIVENESS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-MET; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0032900030     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Booth C, Harnden P, Trejdosicwicz LK, Scriven S, Selby PJ Southgate J: Stromal and vascular invasion in an human in vitro bladder cancer model. Laboratory investigation 76: 843-857, 1997.
2. Bringuier PP, Umbas R, Schaafsma HE, Karthaus HFM, Debruyne FMJ, Schalken JA: Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res 53: 3241-3245, 1993.
3. Rebel JMJ, Thijssen CDEM, Vermey M, Delouvee A. Zwarthoff EC, Van Der Kwast TH: E-cadherin expression determines the mode of replacement of normal urothelium by human bladder carcinoma cells. Cancer Res 54: 5488-5492, 1994.
4. cas) in bladder tumours. Cancer Res 56: 4156-4158, 1996.
5. Heney MM, Ahmed S, Flanagan MJ, Frable W, Corder MP, Haferman MD, Hawkins IR: Superficial bladder cancer: progression and recurrence. J Urol 130: 1083-1086, 1983.
6. Soloway MS: Intravesical therapy for bladder cancer: Urol Clin North Am 15: 661-672, 1988.
7. Raghavan D. Shipley WU, Garnick MB, Russell PJ, Richie JP: Biology and management of bladder cancer. N Engl J Med 322: 1129-1138, 1990.
8. Lipponen PK: Review of cytometric methods in the assessment of prognosis in transitional cell bladder cancer. Eur Urol 21: 177-183, 1992.
9. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Lochner D, Birchmeier W: E-cadherin-mediated cell cell -adhesion prevents invasivesness of human carcinoma cells. J of Cell Biol 113: 173-185, 1991.
10. Tsukita S, Tsukita SA, Nagafuchi A, Yoncmura S: Molecular linkage between cadherins and actin filaments in cell-cell adherens junctions. Curr Opin Biol 4: 834-839, 1992.
11. Birchmeier W, Weidner KM, Hulsken J, Behren J: Molecular mechanisms leading to cell junction (cadherin) deficiency in invasive carcinomas. Seminars in Cancer Biology 4: 231-239, 1993.
12. Garrod DR: Desmosomes and hemidesmosomes. Curr Opinion Cell Biol 5: 30-40, 1993.
13. Kemler R: From cadherins to catenins: cytoplasmic protein interaction and regulation of cell adhesion. TIG 9: 317-321, 1993.
14. Garrod DR: Desmosomes and cancer. Cancer Surveys 24: 97-111, 1995.
15. Mareel M, Berx G, Vanroy F, Bracke M: Cadherin/catenin complex-a target for anti invasive therapy. J Cell Biochem 61: 524-530, 1996.
16. Jiang WG: E-cadherin and its associated protein catenins, cancer invasion and metastasis. Br J Surg 83: 437-446, 1996.
17. Wheelock MJ, Knudsen KA: Cadherins and associated proteins. In vivo 5: 505-513, 1991.
18. Ozawa M, Baribault H, Kemler R: The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J 8: 1711-1717, 1990.
19. Legan PK, Collins JE, Garrod DR: The molecular biology of desmosomes and hemidesmosomes: what's in a name?. Bio Essays 14: 385-393, 1992.
20. Witcher LL, Collins R, Puttagunta S, Mechanic SE, Munson M, Gumbiner B, Cowin P: Desmosomal cadherin binding domains of plakoglobin. J Biol Chem 271: 10904-10909, 1996.
21. Kowalczyk AP, Stappenbeck TS, Parry DAD, Palka HL, Virata MLA, Bornslaeger EA, Nills LA. Green KJ: Structure and function of desmosomal transmembrane core and plaque molecules. Biophys Chem 50: 97-112, 1994.
22. Pauli BU, Cohen SM, Alroy J, Weinstein RS: Desmosome ultrastructure and the biological behaviour of chemical carcinogen induced urinary bladder carcinomas. Cancer Res 38: 3276-3285, 1978.
23. Alroy J, Pauli BU, Weinstein RS: Correlation between numbers of desmosomes and the aggressiveness of transitional cell carcinoma in the human urinary bladder. Cancer 47: 104-112, 1981.
24. Green KJ, Stappenbeck TS, Noguchi S, Oyasu R, Nilles LA: Desmoplakin expression and distribution in cultured rat bladder epithelial cells of varying tumourigenic potential. Exp Cell Res t 134-143, 1991.
25. Kocher O, Amaudruz AM, Gabbiani G: Desmosomes and gap junction in percarcinomatous and carcinomatous conditions of squamous epithelial. J Submicroscopic Cytol 13: 267-281, 1981.
26. Schindler AM, Amaudruz MA, Kocher O, Riotton G, Gabbiani G: Desmosomes and gap junctions in various epidermoid preneoplastic anc neoplastic lesions of the cervix uteri. Acta Cytologica 26: 466-470, 1981.
27. Demlehner MP, Schafer S, Grund C, Franke WW: Continual assembly of half desmosomal structures in the absence of cell contacts and their frustrated endocytosis: a coordinated sisyphus cycle. J Cell Biol 131: 745-760, 1995.
28. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Tashiro K, Shimizu S: Molecular cloning and expression of human hepatocyte growth factor. Nature 342: 440-443, 1989.
29. Stoker M, Gherardi E: Regulation of cell movement. Biochem Biophys Acta 1072: 81-102, 1991.
30. Faletto DL, Kaplan DR, Halverson DO, Rosen EM, Vande Woude GF: Signal transduction in c-Met mediated motogenesis. In: Hepatocyte growth factor-scatter factor (HGF-SF) and the c-Met receptor (Goldberg ID and Rosen EM eds). Birkhauser Verlag. Basel 1993, pp. 107-130.
31. Jiang WG, Hiscox S: Hepatocyte growth factor/scatter factor, a cytokine playing multiple and converse roles. Histol Histopathol 12: 537-555, 1997.
32. Rosen E, Meromsky L, Setter E, Vinter DW, Goldberg ID: Smooth muscle-derived factor stimulates mobility of human tumor cells. Invasion Metastasis 10: 49-64, 1990.
33. Weidner KM, Behrens J, Vandekerckhove J, Birchmeier W: Scatter factor: Molecular characteristics and effect on the invasiveness of epithelial cells. J Cell Biol 111: 2097-2108, 1990.
34. Jiang WG, Hiscox S, Hallett MB, Scott C, Horrobin DF, Puntis MCA: Inhibition of hepatocyte growth factor/scatter factor induced motility and invasion of human cancer cells by gamma linolenic acid. Br J Cancer 71: 744-752, 1995.
35. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, Mcewan RN: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Can Res 47: 3239-3245, 1987.
36. Koch PJ, Franke WW: Desmosomal cadherins, another growing multigene family of adhesion molecules. Curr Opinion Cell Biol 6: 682-687, 1994.
37. Hiscox S, Jiang WG: Expression of E-cadherin, α-, β-and γ-catenin in human colorectal cancer. Anticancer Res 17: 1349-1354, 1997.
38. Jiang WG, Singhrao SK, Hiscox S, Hallett MB, Bryce RP, Horrobin DF, Puntis MCA, Mansel RE: Regulation of desmosomal cell adhesion in human tumour cells by polyunsaturated fatty acids. Clin Exp Metastasis 15: 593-602, 1997.
39. Graff J, Herman J, Lapidus R, Chopra H, Xu R, Jarrard D, Isaacs W, Pitha P, Davidson N, Baylin S: E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 55: 5195-5199, 1995.
40. Shimoyama Y, Nagafuchi A, Fujita S, Gotoh M, Takeichi M, Tsukita S, Hiorhashi S: Cadherin dysfunction in a human cancer cell line: possible involvement of loss of α-catenin expression in reduced cell-cell adhesiveness. Cancer Res 52: 5770-5774, 1992.
41. 2+ -dependent cell-cell adhesion. Cell Adhesion Commun 1: 239-250, 1993.
42. Morton RA, Ewing CM, Nagafuchi A, Tsukita S, Isaacs WB: Reduction of E-cadherin levels and deletion of the alpha-catenin gene in human prostate cancer cells. Cancer Res 53: 3585-3590, 1993.
43. Matsuyoshi N, Hamaguchi M, Taniguchi S, Nagafuchi A, Tsukita S, Takeichi M: Cadherin-mediated cell-cell adhesion is perturbed by v-src tyrosine phosphorylation in metastatic fibroblasts. J Cell Biol 118: 703-714, 1992.
44. Sommers CL, Gelmann EP, Kemler R, Cowin P, Byers SW: Alterations in beta-catenin phosphorylation and plakoglobin expression in human breast cancer cells. Cancer Res 54: 3544-3552, 1994.
45. Takayama T, Shiozaki H, Shibamoto S, Oka H, Kimura Y, Tamura S, Inoue M, Monden T, Ito F, Monden M: β-catenin expression in human cancers. Am J Path 148: 39-46, 1996.
46. Rubinfeld B, Souza B, Albert I, Muller O, Chamberlain SH, Masiarz FR, Munemitsu S, Polakis P: Association of the APC gene product with beta-catenin. Science 262: 1731-1734, 1993.
47. Su LK, Vogelstein B, Kinzler KW: Association of the APC tumor suppressor protein with catenins. Science 262: 1734-1737, 1993.
48. Hulsken J, Birchmeier W, Behrens J: E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton. J Cell Biol 127: 2061-2069, 1994.
49. Nollet F, Van Den Berg A, Kersemaekers A-M, Cleton-Jansen A-M, Berx G, Van Der Veen AY, Eichperger C, Wieland I, De Greve J, Liefers G-J, Xiao W-H, Buys CHCM, Cornelisse C, Van Roy F: Allelic imbalance at the β-catenin gene (CTNNB1 at 3p22-21.3) in various human tumor types. Int J Oncol 11: 311-318, 1997.
50. Navarro P, Lozano E, Cano A: Expression of E-and P-cadherin is not sufficient to modify the morphology and the tumourigenic behaviour of murine spindle carcinoma cells. Possible involvement of plakoglobin. J Cell Sci 105: 923-934, 1993.